
Venture capital · Early stage · Est. 2007
The Column Group
The Column Group is a San Francisco-based life sciences venture firm that forms and funds biotech companies, supporting them from inception through exit with a family of related funds.
Investment activity
Round-by-round activity is part of PRO
Key signal this week
Is The Column Group right for your round?
Key stats
Fund cycle Public record
Fund vehicles on public registers (SEC adviser filings). Values are the gross assets each filing reports, not fund sizes.
Latest investments
BetaRounds The Column Group joined, from press and the firm’s own posts.
6 rounds in the last 12 months
Round sizes, The Column Group’s role and who invested alongside.
Notable portfolio
Portfolio and exits
Every company The Column Group backed and how the exits played out.
Where the money goes
Share of companies at first investment, from the rounds we track.
Investment team
Where to meet The Column Group
Events where The Column Group’s team spoke or showed up, from event programmes, press and the firm’s own posts.
Signals
Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.
Founders also look at
Frequently asked questions
The Column Group is based in San Francisco, United States.
In 2007.
15 fund vehicles are on public registers (SEC adviser filings), including THE COLUMN GROUP IV, LP, THE COLUMN GROUP V LP and THE COLUMN GROUP OPPORTUNITY III LP.
Stages: Early stage. Sectors: Life sciences. From the firm’s own website.
TCG focuses on company formation in biotech, backing science-driven teams from early platform and drug discovery through later-stage programs and exit. It runs an ecosystem of funds with distinct strategies and offers hands-on help with leadership and talent recruitment. From the firm’s own website.
The Column Group lists 43 portfolio companies on its website, including Sentrin Therapeutics, Topo Therapeutics, Nilo Therapeutics, Surrozen and Monimoi Therapeutics.
Firms whose websites list some of the same companies include RA Capital, Atlas Venture and Foresite Capital.
Know before The Column Group’s next round is announced.
PRO tracks The Column Group’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.